Allen Jeremias MD in Roslyn, New York

Home New York Roslyn

Allen Jeremias MD has Interventional Cardiology as his primary medical specialty. Their primary office is: 100 Port Washington Blvd in Roslyn, New York.

They're a part of the: Chs Physician Partners Pc medical group which has around 508 members. You can call their office at 516-390-9640 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1995 (around 29 years of experience). They are listed as doing telehealth appointments.

Allen Jeremias MD Office Phone and Directions

Allen Jeremias MD
Chs Physician Partners Pc
100 Port Washington Blvd
Roslyn, New York 11576
516-390-9640

Patient Ratings
Please rate your experience with Allen Jeremias MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 516-390-9640

Enter a starting address:

Healthcare Info for Allen Jeremias MD

Additional Medical Specialties Include:
CARDIOVASCULAR DISEASE (CARDIOLOGY)

Medical School: Sorry, his university is not listed
Graduation Year: 1995
The Primary Medical Specialty for Allen Jeremias MD is listed as: Interventional Cardiology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 29
PAC (PECOS ID)#: 0840299392
NPI #: 1427138395
NPI Created On: 10/16/2006
NPI Last Updated Listed as: 08/23/2013
Primary Taxonomy Code: 207RC0000X
License Number:
242096
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Catheter insertion of stents in major coronary artery or branch, accessed through the skin
Removal of plaque and insertion of stent in major coronary artery or branch, accessed through the skin
Insertion of stent, removal of plaque and/or balloon dilation of coronary vessel, accessed through the skin
Ultrasound evaluation of heart blood vessel or graft
Ultrasound evaluation of heart blood vessel or graft
Routine ekg using at least 12 leads including interpretation and report
Insertion of catheter in left heart for imaging of blood vessels or grafts and left lower heart
Insertion of catheter in left heart for imaging of blood vessels or grafts and left lower heart
Insertion of catheter in right and left heart for imaging of blood vessels or grafts and left lower heart
Ultrasound evaluation of heart blood vessel during diagnosis or treatment
Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 15 minutes
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 45 minutes
Established patient office or other outpatient, visit typically 25 minutes
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Physician telephone patient service, 21-30 minutes of medical discussion

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $125

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788223463

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $10

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788223465

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $10

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788223467

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $10

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788223469

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $121

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 777644019

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: PAIN MANAGEMENT

Name of Drug #1: GENERAL THERAPIES

Payments Total: $413

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third Party:: GILUI CONSULTING INC

Third party is a Charity:: No

Record ID:: 777644021

Being Disputed:: No

Product Related: Yes

Drug or Biological: Device

Product Category #1: PAIN MANAGEMENT

Name of Drug #1: COMET

Payments Total: $1,530

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 810705695

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Diabetes

Name of Drug #1: RYBELSUS

Open Associated Drug #1: 0169-4303-13

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 810848979

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Diabetes

Name of Drug #1: Ozempic

Open Associated Drug #1: 0169-4132-12

Payments Total: $3,900

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third Party:: GILUI CONSULTING, INC.

Third party is a Charity:: No

Context of payment:: The reported payment reflects the amount provided to a third party employer or institution in connection with services provided by the covered recipient. Novo Nordisk Inc. does not know how much, if any, of this amount was actually received by the covered recipient.

Record ID:: 811046993

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Diabetes

Name of Drug #1: Ozempic

Open Associated Drug #1: 0169-4132-12

Payments Total: $122

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 811051403

Being Disputed:: No